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Abstract

In recent times, psychedelics are back in the public eye, mostly through scientific intrigue
about their healing potential. In the past decade, hundreds of studies have been conducted to
explore the possible benefits, or risks, that these substances could bring to people – and there is
great potential being found. This is the psychedelic renaissance, and with this phenomenon in
full swing, it is important to take a step back and look at the full picture of our history with these
substances. By doing so, it starts to become clear that psychedelics have guided human
perception and understanding of our world for a very long time. The recognition of how
important these substances are did not start last year or within the decade, or even back in the
20th century with Albert Hoffman’s discovery of LSD. Humankind have been utilizing these
substances for thousands of years – and the spiritual significance they contain for Indigenous
people is almost unfathomable. That being said, the current psychedelic renaissance is being
guided almost entirely by science and academia – as it has been since the colonization of
Indigenous people, followed up by a Western takeover of the psychedelic healing paradigm
starting in the late 1940’s. This literature review aims to catalog and make clear the role of
Indigenous practices within psychedelic healing, and explores how a White-dominant scientific
understanding of the same phenomenon has overshadowed these previous understandings, and
why that is problematic. It’s not that one understanding is better than the other – but due to
factors of structural racism, the same individuals who have been utilizing these healing practices
for thousands of years are now being barred from the current conversations.
There are multiple sections to this paper. First, there is an extensive history section that
outlines both ancient history, as well as modern history starting in the 1940s and moving through
to the present day. Then, to gain insight into our recent scientific understanding, I shall outline
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the research behind why these substances are coming back into current conversations about
healing. I will then make a case for the convergence of Indigenous knowledge and science,
ending with a request to the scientific community to be more aware of the role BIPOC
communities have in this renaissance – and to be aware that they are not being included as they
rightfully should. By not including Indigenous voices and knowledge, we lose the thousands of
years of experience and insight into the benefits these powerful substances can have, as well as
possible risks and how best to avoid them.
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Ancient History
The history of psychedelics goes much further back in time and is deeper and more
complex than many of those in the Western world might initially acknowledge (El-Seedi et al.,
2005), (Miller et al., 2019), (Rätsch, 2005), (Stamets, 1996). In this section I shall be outlining
the ancient human history of three important plant medicines: psilocybin, peyote/mescaline, and
Ayahuasca, as they are some of the most frequently documented substances from human history.
I shall briefly discuss why each of these “entheogens” were so important to these peoples from a
historical sociocultural standpoint. For clarity, entheogens can be described as any psychedelic or
psychoactive drug that is taken for the express purpose of spiritual or religious practice (Ruck, et
al., 1979). All three psychedelics referenced in the ancient history section of this paper are
considered entheogens, as the Indigenous people that used them did so for spiritual reasons. I
will then move on to more modern history, starting with the discovery of lysergic acid
diethylamide - otherwise known as LSD. I will discuss the use and importance of LSD
throughout the 1960s and 70s, and at the end of the movement related to U.S. President Richard
Nixon and the “War on Drugs.” After that we will swing back around to the present, and discuss
the current psychedelic renaissance.
The purpose of this extensive history section is to show that psychedelic substances are
important to humankind, and have been important for an extremely long time. They are very
long-standing in our history, and have provided humans with a tremendous amount of
information about ourselves and the world (Rätsch, 2005). Beyond that, as we will see in later
sections, they may have significant roles in providing mental and physical health benefits benefits similar to what we see reported in mindfulness practitioners (Frecska et al., 2016),
(Simon & Engström, 2015). I will also briefly discuss what are known as “diseases of
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civilization” (Bynum & Porter, 2006), and how psychedelics could help combat these ailments
(Frecska et al., 2016). There will also be important acknowledgements of the current Western
take-over of the psychedelic movement, and how that could be harmful to the Indigenous groups
that were first to utilize psychedelics (George, et. al, 2020). My aim is to make the case that the
psychedelic renaissance is important, and should be bolstered (safely), as well as ensuring that
BIPOC individuals with psychedelic history and meaningful experience do not get cut from the
discussion.
Psilocybin
Perhaps one of the best-known psychedelics is the fungi-sourced psilocybin – more
commonly known as “magic mushrooms.” It turns out there are reasons it is very well known: to
start, these mushrooms grow in every single continent except for Antarctica. They are incredibly
widespread and normal to find growing just about anywhere mushrooms grow – the most
common areas being wetter, more tropical locations. This is according to a review of the worldwide distribution of psychoactive mushrooms (including but not limited to psilocybin containing
specimens) conducted in 2000 by Gaston Guzman, et. al., which recorded not only the number of
distinct species of hallucinogenic mushrooms, but also catalogued where they grow. There are
over 200 species of Basidiomycota mushrooms that contain psilocybin, the largest genera out of
eleven being Psilocybe, with over 116 species (Guzman et al., 2000). The bulk of these grow in
Mexico (with 53 separate species being found), but are also located in the Northern Americas,
Europe, Asia, Africa, and Australia (and surrounding islands). This means that people all over
the world have had access to hallucinogenic mushrooms, psilocybin containing or otherwise such in the case of the Amanita muscaria mushroom, which was an important entheogen of the
Indigenous people of Siberia (Nyberg, 1992).
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This brings me to my next point: these mushrooms have been making incredible impacts
on the people who consume them for thousands of years. One of the first instances in ancient
human history that we can tangibly see (not to say that they didn’t have importance before then),
are the Mayan “mushroom stones” of Guatemala – carbon dated to 1000 BCE. These statues
were excavated from Mayan ruins and were a clear sign of how revered these mushrooms were
to the people (Borhegyi, 1961). Beyond that, the Aztec even had a word for a species of
Psilocybe mushrooms that they called teonanacatl, otherwise known as “God’s Flesh” (Stamets,
1996). They considered the mushrooms to be holy sacraments, and had several ceremonies and
rituals tied to consuming them. These ceremonies were noted by the Spanish invaders who came
to conquer Mesoamerica in the 16th century, but then were promptly forbidden by said invaders,
in the name of squashing anything they considered to be “satanic” or “pagan idolatry.” (Stamets,
1996). In fact, they tried their best to completely suppress not only the rituals, but anything
related to reverence for the mushroom, included the aforementioned Mayan statues. The deep,
rich and complex history of the mushroom to these people was nearly wiped out entirely
(Stamets, 1996). This is a shame, and also quite interesting to me, considering that the same
world that effectively wiped out the already established power of psychedelics is the same world
that now can’t get enough of it. This will be touched on later in this literature review, however.
For now, the point is that these psychedelics are important to people. This is clear before we
even gain an understanding of the science of why they might be so important.
Peyote/Mescaline
This next substance is less ubiquitous than psilocybin but undoubtedly just as important
to the peoples who have consumed it for thousands of years. Mescaline is a psychedelic
compound that is extracted, usually through means of cooking, from the Peyote cactus, the San
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Pedro cactus, and a couple less well-known cacti. These cacti and the resulting extracted
compound have been used for at least 5,700 years by Native American populations in precolonized Mexico, part of which is now known as Texas. This data was gathered through carbon
dating mescaline “buttons” that were found with other significant cultural material (El-Seedi et
al., 2005). Similar to psilocybin, this psychedelic protoalkaloid1 holds significant religious and
cultural importance to the groups who used it in ritual practice.
One of the first historical documentations of the use of mescaline was recorded by
Spanish colonizers around the late 1600’s and early 1700’s (Jones, 2007). This way of life
continued to be up-rooted during the 1800’s, as tribes were forced away from their homelands
into new, unaccommodating conditions – a place where mescaline containing cacti did not grow.
Through this restriction came a retaliation, however; peyote was slowly being re-introduced into
their lives via horseback trading, and peyote rituals went from unnamed but commonly practiced
rituals to the creation of an entire church based around the cactus. It is unclear exactly which
tribe established the NAC (Native American Church), but the church’s main goal was to protect
and strengthen the Native American right to perform peyote rituals (Jones, 2007).
The NAC served as a way to band together tribes and individuals under symbology and
meaning – but beyond that, peyote rituals served to provide a “needs‐based solution to
psychological problems Native Americans were encountering in the newly enforced reservation
system” (Jones, 2007). In this case, the consciousness-expanding power of mescaline would help
NAC members to “heal physical, mental, and spiritual imbalances within themselves and among
their social relations, helping to assuage the effects of the needs‐denying arrangements of the
1

A protoalkaloid is a type of alkaloid (a naturally occurring organic compound produced by living
organisms including plants, bacteria, fungi and animals) originating from amino acids. Many
protoalkaloids are also psychoactive in nature (Aniszewski, 2015).
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reservation system” (Jones, 2007). The point here is that despite any attempts to quell or
suppress the use of psychedelics, those who are able to harness its power for healing will fight
for their right to do so, regardless of how difficult that fight may be. This again points to the
importance of psychedelic compounds to these individuals.
Ayahuasca
Ayahuasca, otherwise known as the “vine of the soul” in the Quechua language (Luna,
2011) is a brew made by the Indigenous peoples who reside in the Amazon basin. The primary
psychoactive compound contained within the brew is N,N-Dimethyltryptamine (more commonly
known as DMT) which is extracted from the Psychotria viridis shrub (or other DMT containing
plants) through a process of boiling (Riba et al., 2003). This preparation is more than simply
DMT, however. What sets Ayahuasca apart from other DMT preparations is the inclusion of the
Banisteriopsis caapi vine. This vine, when boiled, releases a monoamine oxidase inhibitor
(MAOI), a type of psychoactive compound that is quite well known in the United States and
around the world for its anti-depressant effects. These specific alkaloids contained within the
vine are known as harmine, harmaline, and tetrahydroharmine (Riba et al., 2003). These
alkaloids prevent deamination of DMT in the gut when combined, meaning that the DMT does
not break down as easily and this leads to more exposure, with stronger and longer lasting effects
(Ruffell et al., 2020).
As with psilocybin and mescaline, it is impossible to know the true ancient history of its
use, although it is speculated to reach back millennia. However, there is physical evidence of the
use of Ayahuasca dating back to 1,000 years ago. This evidence was extracted and carbon-dated
from what was deemed a “ritual bundle,” a fox-snout pouch carefully stitched together, implying
the importance of it as an entheogen to the Indigenous folks who partook (Miller et al., 2019).
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Aside from physical evidence, we also have anthropological evidence stemming from Spanish
and Portuguese colonizers who demonized and attempted to fully eradicate Ayahuasca rituals
from Indigenous South America (Soibelman, 1995). We can start to notice a theme here:
Indigenous cultures discover and have significant use for these entheogens which they utilize for
thousands of years, until the Western world attempts to abolish anything they consider to be
“satanic” in the name of Christian theology (Stamets, 1996). This is important to realize as the
psychedelic renaissance continues to unfold within the Western world - these substances have
been around for much, much longer than we may give credit for.
Modern Western History of Psychedelics
Just as it is important to recognize the ancient world history of psychedelics, we must
also acknowledge the more recent and scientifically based Western understanding of these
fascinating compounds. I would like to note that neither approach is necessarily more valid, and
that both perspectives may contribute to a richer and more insightful understanding of the
meaning and significance of these substances to humankind.
Albert Hoffman’s Discovery of LSD
An appropriate place to start when considering the scientific history of psychedelics
(mainly due to the historical significance and popularity of this event) is the discovery of an
important chemical compound - one that would change the life of its discoverer and many people
after him: that being Albert Hoffman’s discovery of Lysergic Acid Diethylamide, otherwise
known as LSD. As stated in Hoffman’s 1996 speech LSD: Completely Personal, the initial
synthesis happened on November 16th, 1938. Hoffman was experimenting with ergot alkaloids to
“obtain a novel, improved circulatory stimulant” (Hoffman, 1996). At first, he was unsure of its
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efficacy for much of anything, and left the chemical synthesis alone for the next five years, until
one day he had the urge to experiment with the substance again. He recounts that his first
exposure was accidental, and so on April 19th, 1943, he purposely dosed himself and went on
what he described as a “horror trip.” While that sounds unpleasant at best, that didn’t stop him
from realizing LSD’s potential and he continued to study the chemical. (April 19th is now
affectionately known for many who partake as “Bicycle Day,” in reference to Hoffman’s ride
home while under the influence.)
He later describes his “horror trip” as frightening at points, but also enlightening
(Hoffman, 1996). This leads to the modern idea that there is no such thing as a “bad trip,” but
rather challenging trips that can be learned from. Michael Pollan, a modern (and quite popular)
psychedelic researcher and writer, and Bridget Huber, his research assistant, write about their
findings of a Johns Hopkins survey taken on the challenging experiences people had under the
influence of psilocybin: “…interestingly enough, despite these negative experiences, many of the
survey respondents still found even these bad trips to be meaningful and spiritually important.
For 34 percent of participants, their most challenging trip on psilocybin was ranked among the
top five most meaningful experiences of their life. And 31 percent said it was among the top five
most spiritually significant experiences of their life. Eighty-four percent of the respondents said
they had benefited from the challenging parts of their trip and 46 percent said they would repeat
that session if they could, despite the challenges” (Huber & Pollan, 2020).
So being that Albert Hoffman was a Swiss scientist, how did LSD make its way over to
the United States? Well, to start, the Swiss laboratory that held its discovery was intrigued by
LSD’s possible usefulness, and thus became a commercially available medication (under the
name Delysid) for a variety of different psychiatric uses in 1947, following the 1943 patent of the
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substance (Hoffman & Stoll, 1943). Then in 1949, the same laboratory that assigned the patent in
Switzerland brought the US government to the attention of LSD citing possible usefulness in
clinical applications, that laboratory being Sandoz Laboratories (Pollan, 2019). This introduction
launched a decades long battle for and against LSD on all sides (civilian, government, and
scientific.) Even Time magazine published six separate reports about the positive benefits of
LSD, from 1954 to 1959 (Shafer, 2010).
There is a sizeable amount of LSD history contained within the decades of the 1950 and
1960s, and so I will do my best to keep the information concise. Essentially, throughout the
1950’s, there were a growing number of researchers looking at the possible uses of LSD, starting
with a method of producing “model psychosis,” through which mental illness could be studied.
This is indicative of the approach towards psychology at the time, which was primarily focused
on the “illness” side of mental illness (Langlitz, 2006). An important name throughout all this is
Sidney Cohen, a leading research authority on LSD in the 1950’s. After having taken the
substance for the first time on October 12th, 1955, he recounts his experience as being
surprisingly positive, considering the current mental illness rhetoric that was being pushed by
fellow researchers, as we can see here:
“[Cohen] expected to feel catatonic or paranoid, but instead, he wrote, ‘I was taken by
surprise. This was no confused, disoriented delirium, but something quite different.’ His
subsequent report described feeling an elevated peacefulness, as if ‘the problems and strivings,
the worries and frustrations of everyday life vanished; in their place was a majestic, sunlit,
heavenly inner quietude.... I seemed to have finally arrived at the contemplation of eternal truth’”
(Novak, 1997). After this personal discovery he teamed up with another important name in
psychedelic history: Aldous Huxley. Together with Betty Eisner, the team explored whether or
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not LSD could be helpful to facilitate psychotherapy, address alcoholism and enhance creativity
(Novak, 1997).
Studies continued on into the 60s and even the mid-70’s as LSD grew in popularity, both
among the masses and among academic researchers. This includes Richard Alpert, better known
as Ram Dass, who was also experimented on using LSD during MK Ultra2; and Timothy Leary,
a psychology professor at Harvard, who is known for his activism in making LSD publicly
known and revered among counterculture groups at the time. The two worked together to
perform dubious (by today’s standards) scientific research at Harvard, until they were both
kicked from the school altogether, fueling Leary’s activism. This advocacy, however, may have
backfired – as even Albert Hoffman states in his book LSD: My Problem Child:
“The evolution of LSD from remedy to inebriating drug was, however, primarily
promoted by the activities of Dr. Timothy Leary and Dr. Richard Alpert of Harvard
University” (Hoffman, 2009).
This brings me to an important aside. These substances are powerful - and cannot and
should not be taken or given out with negligence. With great power comes great responsibility and I’m afraid that, at least in their years of research, Timothy Leary and Richard Alpert did not
do their due diligence to keep people safe and to keep their research sane (Hoffman, 2009).
According to Hoffman’s firsthand accounts of his 1970s meetings with Dr. Leary, the LSD
apostle (as he was known at the time) had slipped away from pure scientific method and into his

2

MK Ultra was a US governmental CIA program that wrongfully and destructively experimented with
LSD on vulnerable subject groups – including mentally ill patients, prisoners, drug addicts and sex
workers in the 1950’s. The group claims this was necessary in order to determine if LSD was effective as
a “truth serum” they could use on prisoners of war. All of this is considered extremely unethical by
today’s research standards (Linville, 2016).
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own “experimentation,” hosting LSD parties that were far removed from their original scientific
purpose (Hoffman, 2009). Hoffman describes him as a passionate person who is very sure of his
mission – so much so that he had lost sight or frequently overlooked the potential downfalls or
risks to psychedelic therapy (Hoffman, 2009). This is part of the reason we must move forward
into further psychedelic research with the utmost care and consideration. Because of institutional
review boards (IRBs), which engage community members to help evaluate research proposals
before approval and require informed consent, research is done more ethically today. There is no
reason to blindly fear these substances – it just pays to be mindful.
The War on Drugs
Due to in part of the unfortunate mishandling of these powerful substances, in the year
1966 LSD was declared a Schedule 1 substance, the most illegal a drug could be (Affairs, 1999).
Richard Nixon, elected as the President of the United States in 1969, is perhaps best known for
his involvement in the Vietnam War, his Watergate scandal that lost him his presidency and
credibility and for starting the global campaign known as the “War on Drugs,” that continues to
this day – despite the controversy that surrounds it (Gonzalez et al., 2019).
While a “War on Drugs” may perhaps at first sound like a helpful thing which could
prevent addiction and general harm to users, there are many underlying problems at play here.
Perhaps most importantly, the war on drugs could be argued as not a war on drugs, but a war on
people that the government deems less desirable. This included those struggling with drug use
disorders, who are themselves generally viewed by the Drug Enforcement Agency (DEA) and
other governmental agencies as dangerous criminals, rather than people with mental illness who
need help, thanks to the stigma that the war on drugs helps perpetuate (Buchanan & Young,
2000) – but notably this also includes and disproportionally affects POC, particularly low-
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income Black and Latinx communities (Rosino & Hughey, 2018). This is an element of a much
larger, systemic problem that we face in our current culture, that being structural racism. Before
we can recognize the role of structural racism in the War on Drugs, we must first gain an
understanding of what structural racism is.
From a 2004 presentation written by Keith Lawrence and Terry Keleher for a Race and
Public Policy Conference: “Structural Racism in the U.S. is the normalization and legitimization
of an array of dynamics – historical, cultural, institutional and interpersonal – that routinely
advantage Whites while producing cumulative and chronic adverse outcomes for people of color.
It is a system of hierarchy and inequity, primarily characterized by White supremacy – the
preferential treatment, privilege and power for White people at the expense of Black, Latino,
Asian, Pacific Islander, Native American, Arab and other racially oppressed people” (Lawrence
& Keleher, 2004). Structural racism is embedded into the very fabric of society, and affects
BIPOC (Black Indigenous People of Color) on nearly all levels – but particularly when it comes
to health inequities (Bailey et al., 2021). Structural racism is not just about prejudices held by
individuals, but goes beyond that into the production and reproduction of laws, rules, and
practices that are enforced and upheld by governmental institutions, within economic systems
and in social and cultural norms (Bailey et al., 2021), (Bailey et al., 2017), (Rothstein, 2017).
In a 2018 study of the War on Drugs and its relation to structural racism, authors Michael
L. Rosino and Matthew W. Hughey have taken 30 years’ worth of news content relating to the
topic and from there proposed a framework that “considers the history of racially motivated laws
and practices and moral panics among Whites who have blamed drug-related social problems
and crime on marginalized racial groups” (Rosino & Hughey, 2018). They argue that drug law
enforcement is unnecessarily violent, forceful, and usually ends in imprisonment - which hits
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marginalized groups particularly hard and lends itself to perpetuating structural racism (Rosino
& Hughey, 2018). They outline a growing body of research that examines the “racialization and
expansion of the American justice system and its social ramifications” (Rosino & Hughey,
2018). Essentially, their findings point to racial oppression in the United States related to the
racialization and militarization of drug enforcement policies. Marginalized communities are
targeted due to the fear around racial groups as being threatening or dangerous, even though
Whites tend to engage in more drug offenses than their BIPOC counterparts:
“Empirical evidence overwhelmingly demonstrates Blacks are targeted for arrest and
punishment in disproportion to their actions relative to Whites. However, many politicians, legal
authorities, members of the public, and even criminologists fail to identify racial prejudice and
discrimination as systemic factors in criminal justice” (Rosino & Hughey, 2018).
As is evident from the article, the War on Drugs has had devastating effects on the exact
communities that need to be protected. I feel that it is of the utmost importance that one of the
goals of the modern-day Psychedelic Renaissance should be to recognize these elements of the
fight against the War on Drugs, considering the White-dominant medical framework that resides
at the forefront of the renaissance. Indigenous communities have always utilized psychedelics in
very deeply meaningful ways, so I believe that we must strive to include BIPOC individuals in
our conversations.
The Psychedelic Renaissance
It appears that within the past 10-20 years, psychedelics are once again gaining ground in
the psychological and psychiatric world as powerful tools of healing (Giffort, 2020), (Sessa,
2017). In this section I discuss relationships between brain function and structure, including the
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connection between depression, anxiety, and addiction and what is known as the “Default Mode
Network” of the brain. Psychedelics have the ability, under proper conditions and care, to help
assuage the effects of a malfunctioning Default Mode Network that contributes to all of these
mental ailments. These links shall be made evident through psychological studies, which are
described below.
The Science Behind Psychedelics
A General Overview of the Default Mode Network
In order to understand how psychedelics could possibly benefit someone suffering from
symptoms of depression, anxiety and/or drug use disorders, we must first begin to understand
why we have these symptoms in the first place. Naturally, these mental ailments are incredibly
complicated, and so for the purpose of this paper, we shall be focusing on a very specific
function of the brain in order to keep it concise. This function, and the network of brain regions
involved, is known as the Default Mode Network (hereby referred to as DMN). Essentially, the
DMN is a collection of areas within the cerebral cortex that are responsible for resting-state
activity within the brain. Whenever you are not focused on an “attention-demanding, goaldirected” task, i.e., you are in a “resting” brain state (often described in research articles as the
“control” condition); the DMN is active, and is responsible for “self-referential processing and
mind-wandering” (Raichle, 2015). This refers to both self-evaluation, as well as perceived
evaluation from others (otherwise known as social evaluations). This can clearly be an active
“resting” state. If you have ever wondered why you cannot seem to shut your brain off at 2 am,
wanting to sleep but instead thinking about that one time in 8th grade where that embarrassing
thing happened – you can thank your DMN for that.
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Beyond the classical understanding of the DMN being an ‘intrinsic system’ – meaning
that it’s an internally oriented process of the brain responsible for self-reference, daydreaming,
and thoughts about the past and future – the DMN may also be a ‘sense-making’ network
(Yeshurun et al., 2021). The two functions seem to work in tandem with one another: “…the
DMN is an active and dynamic ‘sense-making’ network that integrates incoming extrinsic
information with prior intrinsic information to form rich, context-dependent models of situations
as they unfold over time” (Yeshurun et al., 2021). It is still true that the DMN is active during the
brain’s resting state, but it has been suggested that “the response of the DMN is locked to
external stimuli, especially during social interactions, and thus can be considered extrinsic… the
DMN is at the nexus of the interaction between the external and internal worlds” (Yeshurun et
al., 2021).
There is evidence that sufferers of depression, anxiety and substance use disorders all
have altered DMN functionality (Coutinho et al., 2015), (Sheline et al., 2009), (Zhang &
Volkow, 2019). The exact type of disfunction varies between ailments, but it has been shown
that all three alter the regular resting state activities of the brain. In depression, it has been shown
that sufferers fail to normally down-regulate DMN activity, as well as having heightened
responses to stimulus-induced negativity (Sheline et al., 2009). This means that these individuals
are more receptive to negative evaluations of their world, and have a harder time shutting down
those evaluations (Sheline et al., 2009). As for anxiety, the results are fairly similar. For both
depression and anxiety, the same areas and functions have been shown to be altered.
Specifically, the functional connectivity within the anterior portions of the DMN which are
related to self-referential and emotional processes were found to be positively correlated with
those suffering from anxiety and depression (Coutinho et al., 2015). However, the posterior areas
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related to episodic memory and perceptual processing were found to be negatively correlated
(Coutinho et al., 2015). In more simplified terms, individuals suffering from depression and
anxiety are spending more time thinking about and ruminating on social evaluations and
emotions, and have a harder time perceiving and remembering events “correctly” (Coutinho et
al., 2015).
As for substance use disorders (SUDs), it has been shown that the DMN is again not
functioning normally, and this dysfunction is associated with cravings and relapse (Zhang &
Volkow, 2019). Specifically, the resting functional connectivity of the anterior DMN (which as
we learned above, is related to self-referential and emotional processes) decreases, which leads
to poor emotional regulation (relapse) and less care towards the self, allowing one to give in to
cravings without thinking of the negative consequences that action may have on the self (Zhang
& Volkow, 2019). On top of that, the DMN as a whole is overly active during withdrawal and
when in a resting state, leading addicted individuals to ruminate about taking the substances they
are currently withdrawing from (Zhang & Volkow, 2019). We also see disrupted connectivity
between the DMN and cortical regions that deal with executive functioning and memory, making
it difficult for the addicted individual to fully perceive and understand the effects their substance
use disorder is having (Zhang & Volkow, 2019). All of this together leaves these individuals in a
battle against their own brain and chemistry.
Psychedelics and Meditation as Possible Solutions
Now that we know the role the DMN plays in these three afflictions, we can start to look
into methods that help reduce dysfunction in the DMN. Interestingly, both the influence of
psychedelics on the brain, as well as meditation and other mindfulness techniques can have
positive therapeutic results in treating mood disorders, even for treatment resistant individuals

THE PSYCHEDELIC RENAISSANCE

19

(Kelly et al., 2019), (Kenny & Williams, 2007). First, let’s focus on psychedelics. According to a
2018 literature review published on the effects of psychedelics (psilocybin, lysergic acid
diethylamide, ketamine, and ayahuasca) on the DMN, there are significant alterations within the
function of the DMN that may mark the efficacy of psychedelic-assisted psychotherapy.
Fascinatingly, the DMN has been shown to function in the exact opposite way than it does in
mood disorders when sufferers are under the influence of psychedelics (Ruban & Kołodziej,
2018). To clarify, the DMN is found to have increased activity of main nodes, as well as
abnormal functional connectivity when afflicted by mood disorders. Under the influence of
psychedelics, however, the DMN activity is leveled and positive coupling between main nodes is
reduced. This points to a potential functional mechanism for psychedelics’ effectiveness in
combatting mood disorders related to the DMN (Ruban & Kolodziej, 2018).
A study conducted in 2016 by Carhart-Harris at the Imperial College London has shown
that an amazing “sixty-seven percent of participants with treatment resistant depression had
significantly reduced depression symptoms at 1 week, with 40% of participants showing a
sustained response at 3 months post-dose” (Kelly et al., 2019). This is an important finding,
considering that treatment resistant depression is just that: treatment resistant. From my own
experience talking with people experiencing treatment resistant depression, it can be outright
debilitating – so these findings are hugely significant for this population. In fact, the Food and
Drug administration granted psilocybin ‘breakthrough therapy’ status in 2018, and in 2019 and
2020 respectively, Colorado and Oregon decriminalized the possession of psilocybin (Ordinance
301, 2019), (Measure 109, 2021). Once rules are established, permit holders can conduct
psilocybin-assisted therapy within specified centers of healing.
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Slowly but surely the Western world, driven by ethically bound science is catching on to
the knowledge that Indigenous people have understood for thousands of years. Another ancient
knowledge that is being “rediscovered,” within the context of healing mood disorders such as
depression and anxiety, are meditation and mindfulness techniques. Interestingly, mindfulness
evokes similar changes in the brain as psychedelics, specifically within the functionality of the
DMN. Since we can already start to look at specific dysfunctions of the DMN as a biomarker for
diagnosis, we can also start to look at changes within that functionality during the course of
treatment, as a biomarker for the efficacy of said treatment (Simon & Engström, 2015). This was
shown to be accurate with psychedelic-assisted therapy (Ruban & Kołodziej, 2018); although
more research is certainly required in order to make any conclusive statements. Specifically for
the case of meditation, modulation of the DMN is the highest predictor of efficacy for treatment.
In other words, the practice of meditation helps a person suffering from rumination quell their
overactive thought processes (Simon & Engström, 2015).
Researchers have been looking into ways to combine psychedelic-assisted psychotherapy
and mindfulness techniques, considering the potential that both treatments have, as well as the
similarities between how they impact the brain. This research is quite new, and as such must be
tested, as we can see in a 2019 study looking at psilocybin-assisted mindfulness training
conducted by Smigielski, et al. They set up a randomized, placebo-controlled, double-blind study
in which 38 participants were given a single dose of psilocybin before a 5-day mindfulness
retreat. (As an aside, an interesting phenomenon about psychedelics is that they tend to provide
long-lasting benefits (Nichols et al., 2016), and so one dose over the span of 5 days can certainly
be enough to maintain effects.) The researchers started with an fMRI to gain a base level
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understanding of DMN functionality within the participants, and then scanned them again during
resting-state activity as well as during two forms of mindfulness training.
It was found that the psilocybin had a synergistic effect with the mindfulness therapy
sessions. Specifically, the regions of the DMN that mediate a sense of self were found to be
decoupled during the psilocybin-assisted mindfulness sessions, those regions being the medial
prefrontal and posterior cingulate cortices – areas which both psilocybin and meditation affect
(Smigielski et al., 2019). This decoupling from both psilocybin and mediation is associated with
a subjective ego dissolution effect, which in turn predicted “positive changes in psycho-social
functioning of participants 4 months later” (Smigielski et al., 2019). As it turns out, the common
psychedelic moniker of “ego death”3 can indeed be tracked in the brain, on top of being able to
physically track the positive effects that an experience of ego death may have.
Diseases of Civilization
Going along with our theme of Western, science-based knowledge and its modern
convergence with ancient or Indigenous knowledge, I would like to briefly discuss what are
known as “diseases of civilization” – and then how psychedelics may play a role in helping us
overcome these diseases. Technically it can be said that all diseases that affect any civilization at
any period of time can be considered diseases of civilization. However, there are specific
diseases linked to modern-day Western life, such as heart disease and obesity through a high
sugar, high fat diet or unequal access to healthy food or opportunities for exercise and
preventative care (Bynum & Porter, 2006). In fact, it is often those who have inadequate access

As described by Timothy Leary in “The Psychedelic Experience,” a psychedelic “ego death” is the
experience of a “complete transcendence” of the self, in which a sort of death and rebirth of the self can
occur (Leary et al., 1966).
3
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to healthy living (those living under the poverty line, full-time minimum wage workers with
families to feed and racially discriminated groups) that suffer the most from diseases of
civilization, due to environmental aspects of poor working conditions and stress – among other
factors (Bynum & Porter, 2006).
These diseases go beyond the physical, as one could imagine, and into the psychological.
This includes depression, anxiety, ADHD, drug use disorders and more. Combatting these
afflictions under the lens of civilization being the root cause seems like a practice in
hopelessness, considering the overarching structures of capitalism that keep us firmly rooted in
this type of civilization (Matthews, 2019), (Olivier, 2015), (Prins et al., 2015). There may be
hope, however, contained within a specific ancient knowledge that was discussed at the
beginning of this paper – that knowledge being the ritual use of Ayahuasca. This is according to
a literature review conducted in 2016 by Frecska et al., in which the researchers compiled
information pertaining to what Ayahuasca is, what it does to the brain and body, and whether or
not these effects are therapeutically and possibly physically beneficial. Specifically, they studied
its effects against diseases of civilization. For the purpose of this paper, I will focus on the
psychological side, but there is also significant evidence pointing towards a possible role of
DMT in tissue protection and neuro-regeneration, as well as in protection against possible Sig1R receptor related diseases such as cancer and Alzheimer’s disease (Frecska et al., 2016).
A common physiological thread between most diseases of civilization (physical or otherwise)
is chronic Low Oxidative Inflammation (LGI). LGI is caused by constant psychological stress
(such as poor working conditions with little to no access to therapy and time off), environmental
pollution, and even smoking behaviors. LGI is implicated in a number of degenerative diseases,
such as autoimmune diseases, cancer, Alzheimer’s, and most notably for the case of this paper,
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major depression (Aseervatham et al., 2013), (Frecska et al., 2016). Without getting into the
complicated neurobiology of it all, it’s important to note that Ayahuasca acts on the Sig-1R
receptor in a way that helps alleviate the degenerative impacts of LGI on cellular processes. In
other words, LGI causes cellular stress, which over time can have severe effects on the brain and
body. Ayahuasca can potentially act as a broad-spectrum remedy, “which hits the dead center of
the discussed vicious circle of the malfunctioning molecular web involved in oxidative stress”
(Hayashi, 2015), (Frecska et al., 2016).
There is evidence that Ayahuasca may also help those suffering from substance use disorders
due to its direct and indirect effects on both dopaminergic and serotonergic systems: “…the
resolution of addiction through ayahuasca’s therapeutic potentials may act on four levels: (1)
reducing brain DA (dopamine) level in the MDP (mesolimbic dopamine pathways) through
effects on the 5-HT (serotonin) receptors, which in turn (2) interferes with the synaptic plasticity.
This neurochemical mechanism is supported by (3) psychological insights and processing of
repressed traumas, enhancing decision making capabilities, which allows the person to (4)
examine first person transcendental experiences” (Frecska et al., 2016). Let’s break down what
this particular researcher is proposing; thanks to certain mechanisms that Ayahuasca exerts on
the brain, this powerful psychedelic might allow an individual suffering from substance abuse
disorders to gain new insight into the root cause of their addiction (trauma) and hopefully, with
support, overcome it.
As for other mental afflictions, Ayahuasca works similarly, reportedly bringing forth deeply
buried subconscious material in a way that sometimes helps the individual learn about
themselves via illumination of perspectives previously unknown and unseen. This helps the
individual gain insight into maladaptive behavior or emotional and cognitive patterns that are
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otherwise ingrained, and difficult to shake (Frecska, et al., 2016). Ayahuasca helps to encourage
the individual to acknowledge their ingrained emotional and cognitive patterns – and thus offers
the understanding needed to change maladaptive behaviors and thinking (Loizaga-Velder &
Verres, 2014), (Frecska, et al., 2016).
Perhaps Ayahuasca could help heal the ailments that a modern day Western life can produce.
However, there are many considerations that the scientific world must investigate if we go
forward with this type of therapy. We must recognize that the current frameworks of psychedelic
psychological studies and professions are White-dominant (Buchanan, 2020). Not only that, but
the current models and theories for treatment are framed within the White experience, in that
there is little to no understanding of the needs and worldviews of BIPOC individuals – and thus
is generally unhelpful to these populations. (Buchanan, 2020). We must take extra steps to
ensure that low SES and disadvantaged groups, such as BIPOC receive just as much benefit from
this type of healing as their White counterparts. This is especially true as the world of Indigenous
psychedelic use is increasingly appropriated (Labate & Conrad, 2019).
Considerations Towards the Future
The Role and Current Exclusion of BIPOC in Psychedelic Healing
To recap what we have learned so far: psychedelic healing has been an important part of
Indigenous cultures long before Albert Hoffman and the current psychedelic renaissance. That
being said, the scientific basis of the Western understanding of psychedelics is necessary to more
clearly understand what these substances can do for us, and how to keep individuals needing
treatment safe while undergoing psychedelic therapy. Unfortunately, Indigenous peoples are
being left out of this conversation, partly due to the White-dominant medical framework that
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psychology work resides within – considering that the workforce and trainee pipeline are
majority White (APA, 2018). Furthermore, BIPOC communities are not receiving the same level
of benefit from the psychedelic renaissance as White communities (Buchanan, 2020), in that
over 80% of participants in trials are White, with less than 3% being Black (Michaels et al.,
2018). So, what can the individuals with the power of privilege and academia on their side do to
ensure that everyone receives the same treatment? The first step is to listen to BIPOC people and
to learn. As such, let’s take a look at an article written by George, et. al, in 2020 about “The
psychedelic renaissance and the limitations of a White-dominant medical framework: A call for
indigenous and ethnic minority inclusion” (George et al., 2020).
Essentially, there are a few cultural and social forces that have led to the suppression and
even silencing of Indigenous and minority voices within the scientific psychedelic community. It
started in the 1950’s and 1960’s with the appropriation of psychedelics by the White “hippies” of
the time, who specifically wanted to transform themselves with the drugs, music, and
spiritualities of other populations (George et al., 2020), (Saldanha, 2007). Despite their
fascination with other cultures, hippies failed to understand the damage they were doing to the
exact culture they wanted to appropriate, via the perpetuation of negative stereotypes (LemkeSantangelo, 2010). While hippies were trying to transform themselves through transcendental
means, Black and Indigenous populations were being viewed as dangerous, “druggie” criminals
for wanting to do the same or just for being themselves (Williams, Gooden, & Davis, 2012).
More recently, we have mass incarceration of BIPOC individuals and communities that
essentially perpetuate a new type of classist segregation, known as the “New Jim Crow” (George
et al., 2020). BIPOC are more likely to be arrested and charged much more harshly (with longer
sentences) for drug crimes than their White counterparts – despite similar rates of drug usage
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(Forman, 2012). With the fear of life-long imprisonment (or the effects of short term
incarceration on their lives moving forward, such as decreased access to housing and jobs)
looming over their shoulders, BIPOC communities can’t even begin to think of psychedelic
treatment as viable options (George et al., 2020). Furthermore, problems within BIPOC
communities are not seen as problems until the same issues start to affect White communities –
and as such are not recognized until the problems are deeply set (George et al., 2020). Beyond
that, with a history of understandable mistrust towards medical treatments, thanks to horrific
instances like the Tuskegee Syphilis experiments, it is no wonder that the benefits of psychedelic
therapy are not reaching BIPOC communities (George et al., 2020). There is significant work
that needs to be done in recognizing the effects of these traumatic events, and part of that is
ensuring that BIPOC are part of the conversation about psychedelic healing going forwards.
Conclusion
My aim is to make the case that the psychedelic renaissance is important and should be
bolstered (within the safest means possible), as well as ensuring that BIPOC individuals with
psychedelic history and meaningful experience do not get cut from the discussion. There is
scientific evidence that psychedelic therapy could greatly benefit society going forward. But we
must be aware of and include the role of Indigenous knowledge in this shift, considering the
great amount of history these communities have with these substances. It’s also important to
know that right now the benefits of the psychedelic renaissance are not reaching BIPOC
individuals and communities thanks to structural racism and a White-dominated psychological
workforce, among other factors. My hope for this literature review is to bring awareness to the
current gap in accessibility for this therapy, and to demonstrate why we must push for change.
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